ScoreWhy is Surgical Science Sweden AB ?
1
The company is Net-Debt Free
2
Healthy long term growth as Net Sales has grown by an annual rate of 56.77% and Operating profit at 44.68%
3
The company has declared Negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At SEK 51.88 MM has Grown at -41.42%
- ROCE(HY) Lowest at 1.17%
- PRE-TAX PROFIT(Q) At SEK 21.63 MM has Fallen at -31.67%
4
With ROE of 2.01%, it has a attractive valuation with a 0.40 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -73.21%, its profits have fallen by -34.8%
5
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 27.70% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -73.21% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Surgical Science Sweden AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Surgical Science Sweden AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Surgical Science Sweden AB
-73.21%
-0.93
78.42%
OMX Stockholm 30
27.7%
1.79
15.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
56.77%
EBIT Growth (5y)
44.68%
EBIT to Interest (avg)
65.29
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.21
Tax Ratio
30.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.98%
ROE (avg)
4.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.40
EV to EBIT
8.08
EV to EBITDA
5.00
EV to Capital Employed
0.30
EV to Sales
1.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.68%
ROE (Latest)
2.01%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at -15.07 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.12 times
-20What is not working for the Company
NET PROFIT(HY)
At SEK 51.88 MM has Grown at -41.42%
ROCE(HY)
Lowest at 1.17%
PRE-TAX PROFIT(Q)
At SEK 21.63 MM has Fallen at -31.67%
RAW MATERIAL COST(Y)
Grown by 6.59% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.9 times
INTEREST(Q)
Highest at SEK 1.24 MM
Here's what is working for Surgical Science Sweden AB
Debt-Equity Ratio
Lowest at -15.07 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.12 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Surgical Science Sweden AB
Net Profit
At SEK 51.88 MM has Grown at -41.42%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Interest
At SEK 1.24 MM has Grown at inf%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Pre-Tax Profit
At SEK 21.63 MM has Fallen at -31.67%
over average net sales of the previous four periods of SEK 31.66 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Interest
Highest at SEK 1.24 MM
in the last five periods and Increased by inf% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Debtors Turnover Ratio
Lowest at 4.9 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
